UBAP2L and hepatocellular carcinoma: It is currently unclear whether SG assembly in the absence of TIA1 is due to overexpression of other SG components but several (e.g., G3BP1 or UBAP2L) are strongly upregulated in HCC from patients resistant to sorafenib and associated with a poor clinical outcome (Supplementary Figure S18).